BCL2L1 and chondrosarcoma: In contrast, in our study, miR-491-5p, which inhibits Bcl-xL, and miR-342-5p, which downregulates both Bcl-2 and Bcl-xL, did not chemosensitize chondrosarcoma cells to CDDP.